Good Neighbor Pharmacy tops J.D Power customer satisfaction study
VALLEY FORGE, Pa. — J.D. Power’s annual U.S. Pharmacy Study has ranked AmerisourceBergen’s Good Neighbor Pharmacy network the highest in customer satisfaction among chain drug stores. This is the third year in a row that the independent pharmacy network has topped J.D. Power’s study. J.D. Power also gave Good Neighbor Pharmacy the highest of its Power Circle ratings, which are based on feedback from product and service owners.
Good Neighbor Pharmacy received a Customer Satisfaction Index score of 876 out of 1,000 — higher than the average chain drug store score of 842. The study ranks customer satisfaction based on customer feedback for a company’s competitiveness, cost, pharmacist and non-pharmacist staff, and this year’s study looked to 15,000 customers.
“As some of the most accessible healthcare providers, pharmacists have grown, and should continue to grow, their role in driving positive health behaviors and outcomes in their communities,” Good Neighbor Pharmacy President Dave Neu said. “The recognition by J.D. Power is a tremendous honor and indicative of the efforts and achievements of the thousands of independent pharmacists who make up Good Neighbor Pharmacy.”
Some general insights that the study revealed include the fact that a pharmacist’s individual attention can have an impact on loyalty, as 44% of customers who talk to their pharmacists strongly agree that they feel loyal to a pharmacy, compared with 35% of people who don’t talk to a pharmacist. Additionally, front-end sales can be aided by offering health services, as 60% of customers who take advantage of the services buy other merchandise from the pharmacy.
Bayer sponsors Prostate Cancer Awareness Month efforts
WHIPPANY, N.J. — Bayer HealthCare on Thursday announced that it will sponsor community awareness efforts nationwide this September, in honor of Prostate Cancer Awareness Month.
Bayer will expand its educational initiative, Men Who Speak Up, to inform the public about one of the leading causes of cancer death among American men.
"Bayer is committed to supporting prostate cancer awareness and advocacy activities because we know the devastating impact this disease can have on people's lives," Dr. Joseph Germino, Bayer's VP for medical affairs in oncology, said. "For men with advanced prostate cancer, our global survey revealed they aren't speaking up about the warning signs of progressing disease."
Bayer also revealed an updated website (LINK www.MenWhoSpeakUp.com) that features data from the International Prostate Cancer Symptoms Survey and provides educational materials, including a doctor discussion guide and a symptom tracker tool.
The company will sponsor events nationwide throughout September, including educational sessions, conferences, awareness walks and runs for patients and the community. Some of these events include:
- Prostate Cancer Research Institute's Prostate Cancer Conference (Sept. 11 to 13), an annual patient event held in Los Angeles that provides a weekend of educational sessions on the latest treatment options, lifestyle changes and quality of life issues;
- UsToo's 11th Annual SEA Blue Prostate Cancer Walk & Run (Sept. 13), education sessions and free PSA testing in Lincoln Park in downtown Chicago;
- Prostate Health Education Network's Virtual Prostate Cancer Walk (runs through Sept. 18), an online effort to increase awareness about current pressing prostate cancer issues, including early detection, patient care, research and education; and
- ZERO Prostate Cancer Run/Walks (occurring between Aug. 30 to Nov. 21), an annual run/walk series taking place in more than 40 cities across the country as part of the group's effort to make prostate cancer a national priority.
In late September, Bayer will analyze data from a survey of more than 1,200 people affected by advanced prostate cancer from across 10 countries. The results will be released at the 2015 European Cancer Congress in Vienna, Austria on Sept. 25.
CVS Health study marks anniversary of ending tobacco sales
WOONSOCKET, R.I. — A year after deciding to end tobacco sales, CVS Health on Thursday released new data from a CVS Health Research Institute study that shows a reduction in cigarette purchases over the past year.
The study tracked cigarette pack purchases at drug, food, big box, dollar, convenience and gas station retailers in the eight months after CVS/pharmacy stopped selling tobacco products, according to the company, and found a 1% reduction in cigarette pack sales in states where CVS/pharmacy had a 15% or greater share of the retail pharmacy market. Over the same eight-month period, the average smoker in these states purchased five fewer cigarette packs, and approximately 95 million fewer packs were sold.
“One year ago, we stopped selling tobacco products because it conflicted with our purpose of helping people on their path to better health,” Dr. Troyen Brennan, chief medical officer at CVS Health, said. “Today, we are excited to release new data demonstrating the positive impact our decision has had on public health overall as shown by a measurable decrease in the number of cigarette purchases across all retailers.”
The study also revealed a 4% increase in nicotine patch purchases in the states with a CVS/pharmacy market share of 15% of more.
Since CVS removed tobacco products from shelves, the average number of MinuteClinic “Start to Stop” smoking cessation visits per month nearly doubled, according to the company. CVS pharmacists counseled more than 260,000 patients about smoking cessation and filled nearly 600,000 nicotine replacement therapy prescriptions. The company also distributed millions of smoking cessation informational brochures and hundreds of thousands of “Last Pack” toolkits, and educated more than 1 million people via its Online Cessation Hub on CVS.com.
“We know that more than two-thirds of smokers want to quit — and that half of smokers try to quit each year,” Brennan said. “We also know that cigarette purchases are often spontaneous. And so we reasoned that removing a convenient location to buy cigarettes could decrease overall tobacco use. This new data demonstrates that CVS Health’s decision to stop selling tobacco did indeed have a real public health impact.”
CVS Health has also pledged more than $1 million in corporate grants to tobacco cessation and prevention programs such as Campaign for Tobacco-Free Kids, Stand Up To Cancer and American Lung Association’s LungForce, and announced it will launch a school-based tobacco-prevention program with its foundation and Scholastic.
“Today, we are proud to mark our one-year anniversary by building on our commitment to be a meaningful part of the effort to make the next generation tobacco-free,” said Eileen Howard Boone, SVP of Corporate Social Responsibility and Philanthropy at CVS Health and president of the CVS Health Foundation. By partnering with an expert partner in education to launch this new program, we will reach millions of kids across the country with critical tobacco-prevention education.”
The program targets nearly three million children in grades three, four and five, with a second component offered in some pilot markets for students in grades six and seven for early 2016. The middle school component will also include a student engagement program, with the chance to receive incentives such as scholarships and youth-focused community training.